openPR Logo
Press release

Global Absorbable Hemostats Market to grow at a CAGR of 6.47% by 2030, Evaluates DelveInsight | Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech

05-07-2024 08:41 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Absorbable Hemostats Market to grow at a CAGR of 6.47%

As per DelveInsight's assessment, the Absorbable Hemostats Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Absorbable Hemostats have been used, which is expected to drive the demand for Absorbable Hemostats in the upcoming years.

DelveInsight's "Absorbable Hemostats Global Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Absorbable Hemostats companies actively working in the market.

Absorbable Hemostats Overview
Absorbable hemostats are medical devices used to control bleeding during surgical procedures or after traumatic injuries. Unlike traditional hemostatic agents that remain in the body indefinitely, absorbable hemostats are designed to be absorbed by the body over time, eventually breaking down and being metabolized or excreted.

To know more about why North America is leading the market growth in the Absorbable Hemostats market, get a snapshot of the report Absorbable Hemostats Market Trends
https://www.delveinsight.com/report-store/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Absorbable Hemostats Market Insights
Geographically, North America is projected to hold the greatest portion in the Global Absorbable Hemostats market. Additionally, the increasing incidence of spine-related disorders and other conditions is anticipated to further boost the absorbable hemostats market in the United States.

DelveInsight Analysis: The Global Advanced Wound Care market size is anticipated to grow with a CAGR of 6.47% during the forecasted period (2024-2030).

Recent Developments in the Absorbable Hemostats Market Report
• On March 25, 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, announced the strategic regional launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.
• Thus, owing to such developments in the market, rapid growth will be observed in the Absorbable Hemostats market during the forecast period

To read more about the latest highlights related to Absorbable Hemostats, get a snapshot of the key highlights entailed in the Absorbable Hemostats
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Absorbable Hemostats Market
Some of the key market players operating in the Absorbable Hemostats market include - B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, and others.

COVID-19 Impact Analysis on the Absorbable Hemostats Market
The absorbable hemostats market is experiencing an increase in product demand due to several factors, with one significant driver being the growing prevalence of spinal disorders.
Additionally, The absorbable hemostats market experienced significant disruption due to the unprecedented COVID-19 outbreak. Lockdown measures implemented during the pandemic resulted in reduced patient visits and the temporary suspension of non-essential surgical procedures, as priority was given to treating COVID-19 patients. However, with the introduction of vaccines and the subsequent easing of restrictions, normal operations have resumed, driving growth in the absorbable hemostats market during the post-pandemic period, among other things, are some of the factors that could increase the global Absorbable Hemostats market during the forecast period (2024-2030).

Scope of the Absorbable Hemostats Market Report
• Coverage: Global
• Study Period: 2021-2030
• Absorbable Hemostats Market Segmentation By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others
• Absorbable Hemostats Market Segmentation By Formulants: Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others
• Absorbable Hemostats Market Segmentation By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others
• Absorbable Hemostats Market Segmentation By End-User: By End-User (Hospitals, Ambulatory Surgical Centers, Laboratories, And Others
• Absorbable Hemostats Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Absorbable Hemostats Companies: B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, among others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Absorbable Hemostats market are set to emerge as the trendsetter explore @ Absorbable Hemostats
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Absorbable Hemostats Market Report Introduction
2 Absorbable Hemostats Market Executive summary
3 Regulatory and Patent Analysis
4 Absorbable Hemostats Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Absorbable Hemostats Market
7 Absorbable Hemostats Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11. About DelveInsight

Interested in knowing how the Absorbable Hemostats market will grow by 2030? Click to get a snapshot of the Absorbable Hemostats Market Analysis
https://www.delveinsight.com/sample-request/absorbable-hemostats-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports
Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.

Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Absorbable Hemostats Market to grow at a CAGR of 6.47% by 2030, Evaluates DelveInsight | Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech here

News-ID: 3487826 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Hemostats

Absorbable Hemostats Market Overview
In today's dynamic global economy, the absorbable hemostats market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain. 𝐆𝐞𝐭
Hemostats Market Insights, Forecast to 2031
A new Report by DataM Intelligence, titled "Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Hemostats market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Hemostats market has been growing significantly
Hemostats Market Size, Outlook, Overview 2024-2033
The hemostats market size has grown strongly in recent years. It will grow from $3.17 billion in 2023 to $3.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications. The hemostats market size is expected to see strong growth in
Hemostats Market worth $3.7 billion by 2028
Hemostats Market in terms of revenue was estimated to be worth $2.7 Billion in 2023 and is poised to reach $3.7 Billion by 2028, growing at a CAGR of 6.7% from 2023 to 2028 according to a new report by MarketsandMarkets. The significant growth in the number of hospitals and surgical centers is expected to support the growth of the hemostats market, as these are key end users of hemostats. The
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our